Intratio
Loading...
Skip to main content
Model output · Signal date 2026-10-16

Milestone Scientific Inc. (MLSS) Stock Forecast Oct. 16, 2026

Analysis updated on Oct. 16, 2026 (UTC) · Total · absolute moveSwitch to Alpha · NYSE

Follow Unlock full AI forecasts
Rating · 90D ▲ Bullish Exact rating locked
90-day forecast Sign up free to reveal
30-day forecast Total
Rank in coverage Top 35% of 5172 stocks scored
Rank correlation · 90D -21.0% Spearman, 357 dates
Market Cap $29M small-cap · #18 of 27 peers
Summary

Milestone Scientific Inc. (MLSS) stock forecast summary

Our AI ranks Milestone Scientific Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

Milestone Scientific Inc. is a small-cap company with a market capitalization of $29M. It ranks number 18 by market capitalization among the 27 Orthopedic, Prosthetic & Surgical Appliances & Supplies issuers in our coverage with a current forecast.

For MLSS, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -21.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 13.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +5.0%, buy ≥ +3.4%, sell < +1.8%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)

A free account shows the exact forecast, rating and rank of 3 tickers you follow, MLSS included.

Follow MLSS free
Price

MLSS price chart and AI forecast

MLSS
Cross-section · 2026-10-16

How MLSS ranks among 5172 stocks

90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Fundamentals · 2026-06-30

Milestone Scientific Inc. (MLSS) fundamentals

Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Orthopedic, Prosthetic & Surgical Appliances & Supplies peers listed below that report each metric.

Valuation & Market

MetricMLSSIndustry medianRank
Market Cap $29M $76M 18/27
P/B Ratio 8.35x 2.28x 4/22
EPS $-0.08 – –
Book Value/Share $0.04 – –
Revenue/Share $0.13 – –
FCF/Share $-0.01 – –

Profitability & Margins

MetricMLSSIndustry medianRank
ROE -119.4% -25.0% 13/19
ROA -49.6% -12.9% 15/19
ROIC -154.4% -5.7% 22/22
Gross Margin 70.9% 50.2% 2/20
Operating Margin -52.4% -8.7% 15/21
Net Margin -35.6% -14.0% 13/17
EBT Margin -52.7% -19.3% 15/21

Financial Health

MetricMLSSIndustry medianRank
Current Ratio 1.85x 2.57x 20/25
Quick Ratio 1.14x 1.89x 19/22
D/E Ratio 1.41x 0.71x 7/24
Financial Leverage 2.41x 1.71x 7/24
Interest Coverage -310.1x -3.4x 18/21
Working Capital $4M $51M 22/25

Cash Flow

MetricMLSSIndustry medianRank
Operating Cash Flow -$640K -$690K 11/25
Free Cash Flow -$660K $2M 9/16
Capital Spending -$20K -$2M 2/16
FCF/Sales -5.7% 1.2% 11/16
CapEx/Sales 0.2% 1.3% 14/16

Operational Efficiency

MetricMLSSIndustry medianRank
Asset Turnover 1.40x 0.72x 2/18
Inventory Turnover 1.1x 2.1x 18/22
Fixed Assets Turnover 579.0x 5.5x 1/19
Days Inventory 332 days 171 days 5/22

Income Statement

MetricMLSSIndustry medianRank
Total Revenue $12M $110M 15/19
Operating Income -$6M -$6M 12/25
Net Income -$4M -$7M 9/19
R&D Expense $460K $20M 21/22
SG&A Expense $14M $126M 19/22
Cost of Goods Sold $3M $55M 16/22

Dividend & Shareholder Information

MetricMLSSIndustry medianRank
Shares Outstanding 89M – –

Balance Sheet Highlights (USD millions)

Total Current Assets$8M97.2% of assets
Cash & Short-term Investments$2M24.8% of assets
Inventory$3M37.0% of assets
Total Liabilities$5M58.4% of assets
Quarterly Financial Reports

MLSS quarterly financials and insider trading

Industry Peers · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Milestone Scientific Inc. (MLSS) industry peers

Companies classified under the same SEC industry code as Milestone Scientific Inc. (Orthopedic, Prosthetic & Surgical Appliances & Supplies): 27 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Reveal all forecasts · See exact % predictions for all competitors

Sign up free
Company 90-Day AI Forecast (Total) Market Cap P/E Ratio P/B Ratio
MLSS Milestone Scientific Inc. ▲ $29M – 8.4x
ISRG Intuitive Surgical Inc ▼ $150.74B 49.0x 8.3x
STE Steris Plc ▼ $21.71B 28.8x 3.0x
ZBH Zimmer Biomet Holdings, Inc. ▼ $18.12B 18.9x 1.4x
SNN Smith & Nephew Plc ▼ $12.75B 16.7x –
ALGN Align Technology Inc ▶ $10.46B 25.7x 2.5x
MSA Msa Safety Inc ▼ $6.91B 22.2x 4.9x
ESTA Establishment Labs Holdings Inc. ▲ $1.76B – 81.6x
ENOV Enovis Corp ▶ $1.13B – 0.8x
CDRE Cadre Holdings, Inc. ▶ $1.13B 26.9x 3.3x
AVR Anteris Technologies Global Corp. ▶ $590M – 2.4x
SMTI Sanara Medtech Inc. ▼ $305M – 38.4x
INGN Inogen Inc ▶ $166M – 1.0x
LAKE Lakeland Industries Inc ▲ $90M – 0.7x
NTRB Nutriband Inc. ▲ $76M – 14.3x
APT Alpha Pro Tech Ltd ▶ $57M 14.2x 0.9x
COCH Envoy Medical, Inc. ▶ $52M – –
MYO Myomo, Inc. ▲ $48M – 8.2x
LFWD Lifeward Ltd. ▲ $17M – 1.4x
CUPR Cuprina Holdings (Cayman) Ltd ▶ $13M – –
UEEC United Health Products, Inc. ▲ $12M 4.7x –
RGNT Regentis Biomaterials Ltd. ▲ $10M – 2.2x
CLGN Collplant Biotechnologies Ltd ▶ $7M – 1.1x
LGMK Logicmark, Inc. ▲ $1M – 0.1x
BBLG Bone Biologics Corp ▲ $1M – 0.3x
RBOT Vicarious Surgical Inc. ▲ $550K – 0.1x
FEED Envue Medical, Inc. ▼ $340K – –

Where MLSS sits on the market map

Industrial Applications and Services · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Explore the map →
News

Milestone Scientific Inc. (MLSS) stock news

Loading...

FAQ

Milestone Scientific Inc. (MLSS) stock forecast FAQ

What is the Milestone Scientific Inc. (MLSS) stock forecast?

Our AI ranks Milestone Scientific Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

How accurate are Milestone Scientific Inc. stock predictions?

For MLSS, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -21.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 13.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are Milestone Scientific Inc. forecasts updated?

Milestone Scientific Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.

Which companies are Milestone Scientific Inc.'s industry peers?

27 issuers in our coverage, MLSS included, share the SEC industry code Orthopedic, Prosthetic & Surgical Appliances & Supplies. The largest are: Intuitive Surgical Inc (ISRG), Steris Plc (STE), Zimmer Biomet Holdings, Inc. (ZBH), Smith & Nephew Plc (SNN), Align Technology Inc (ALGN), Msa Safety Inc (MSA).

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.